Wordt geladen...
Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab
OBJECTIVES: This study aimed to explore the effects of vascular endothelial growth factor A (VEGFA) gene polymorphisms (rs699947 and rs833061) on Bevacizumab (BEV) treatment in colorectal cancer (CRC) patients. METHODS: 125 CRC cases receiving BEV plus FOLFIRI treatment were recruited in this study....
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739652/ https://ncbi.nlm.nih.gov/pubmed/29285265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22295 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|